How big is The Peripheral Vascular Devices Market?
IMARC Group, a leading market research company, has recently releases report titled “Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that The global peripheral vascular device market size reached US$ 10.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.
What is Peripheral Vascular Devices?
Peripheral vascular disease (PVD) is a medical condition characterized by the constriction, blockage, or spasms in blood vessels located outside the heart and brain. There are various effective tools available for treating PVD, including angioplasty catheters, vena cava filters, stent-grafts, and embolic protection devices (EPD). These peripheral vascular devices are designed to enhance safety, reduce the risk of infection and irritation, improve blood circulation, and deliver oxygenated blood through the arteries. As a result, they are widely utilized in hospitals and clinics worldwide.
Request a free sample brochure: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample
Peripheral Vascular Devices Market Trends and Drivers:
The peripheral vascular devices market is experiencing significant growth due to the rising prevalence of venous diseases, specifically chronic venous insufficiency (CVI), in various countries. Additionally, the increasing elderly population, who are more susceptible to conditions like peripheral artery disease (PAD) and blockages due to physical inactivity and unhealthy diets, is driving market expansion. The market is further boosted by the growing preference for minimally invasive surgeries (MIS) which offer advantages such as fewer complications, reduced postoperative pain, shorter hospital stays, and faster recovery times.
Furthermore, the increasing adoption of atherectomy devices, driven by the growing incidence of atherosclerosis, obesity, and lifestyle-related disorders, is contributing to market growth. Factors such as the expanding healthcare sector, rising disposable income, and extensive research and development (R&D) activities are anticipated to fuel the growth of the peripheral vascular devices market in the foreseeable future.
Who are the key players operating in the industry?
- Abbott Laboratories
- B. Braun SE (B. Braun Holding GmbH & Co. KG)
- Becton
- Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cook Group Incorporated
- Cordis Corporation
- iVascular S.L.U.
- Koninklijke Philips N.V.
- Medtronic plc and Terumo Medical Corporation.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Device Type:
- Peripheral Vascular Stents
- Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
- Peripheral Transluminal Angioplasty (PTA) Guidewires
- Atherectomy Devices
- Embolic Protection Devices
- Inferior Vena Cava Filters
- Others
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Care Centers
- Specialty Clinics
- Others
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/peripheral-vascular-devices-market
Breakup By Regions:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/